NCT05434559View on ClinicalTrials.gov

Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec

CompletedOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

February 20, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin Degludec

Switch during standard routine care to Insulin Degludec.

Trial Locations (2)

2650

University Hospital Antwerp, Wilrijk

3000

Universitaire Ziekenhuizen Leuven, Leuven

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

prof dr Pieter Gillard

OTHER